Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1989 Sep;42(9):982–984. doi: 10.1136/jcp.42.9.982

Use of monoclonal anti-actin as a megakaryocyte marker in paraffin wax embedded bone marrow biopsy specimens.

C Boqué 1, N Pujol-Moix 1, M A Linde 1, C Murcia 1, C Guanyabens 1, J Soler 1
PMCID: PMC501800  PMID: 2677054

Abstract

Monoclonal anti-actin was used as a marker of megakaryocytes in Zenker's fixed, paraffin wax embedded bone marrow tissue, using an immunoperoxidase staining method. Twenty bone marrow samples were studied, including controls, and different myeloproliferative and myelodysplastic syndromes. The results were compared with those obtained using factor VIII related antigen (F VIII RAg) immunolabelling. Anti-actin is as good a marker for megakaryocytes as anti-FVIIIRAg and is potentially clinically useful when morphological identification is difficult, when bone marrow aspiration is unsuccessful, or when quantitative evaluation of tissue sections is required.

Full text

PDF
982

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adány R., Kiss A., Muszbek L. Factor XIII: a marker of mono- and megakaryocytopoiesis. Br J Haematol. 1987 Oct;67(2):167–172. doi: 10.1111/j.1365-2141.1987.tb02321.x. [DOI] [PubMed] [Google Scholar]
  2. Crocker J., Smith P. J. Value of factor VIII related antigen as a means of demonstrating extramedullary megakaryopoiesis. J Clin Pathol. 1984 Jul;37(7):834–835. doi: 10.1136/jcp.37.7.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hruban R. H., Kuhajda F. P., Mann R. B. Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia. Am J Clin Pathol. 1987 Nov;88(5):578–588. doi: 10.1093/ajcp/88.5.578. [DOI] [PubMed] [Google Scholar]
  4. Mukai K., Schollmeyer J. V., Rosai J. Immunohistochemical localization of actin: applications in surgical pathology. Am J Surg Pathol. 1981 Jan;5(1):91–97. doi: 10.1097/00000478-198101000-00013. [DOI] [PubMed] [Google Scholar]
  5. Nachmias V. T. Platelet and megakaryocyte shape change: triggered alterations in the cytoskeleton. Semin Hematol. 1983 Oct;20(4):261–281. [PubMed] [Google Scholar]
  6. Vainchenker W., Kieffer N., Cramer E., Vinci G., Debili N., Henri A., Titeux M., Guichard J., Mishal Z., Breton-Gorius J. Expression of platelet proteins during maturation of human megakaryocytes and of the K 562/HEL cell lines. Prog Clin Biol Res. 1986;215:227–240. [PubMed] [Google Scholar]
  7. Vinci G., Tabilio A., Deschamps J. F., Van Haeke D., Henri A., Guichard J., Tetteroo P., Lansdorp P. M., Hercend T., Vainchenker W. Immunological study of in vitro maturation of human megakaryocytes. Br J Haematol. 1984 Apr;56(4):589–605. doi: 10.1111/j.1365-2141.1984.tb02184.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES